CIK 0001649094
- Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464233385
- Phone
- +1 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- 4 Grant or award Director acquired 2,500 shares (grant or award)
- 4 Grant or award Director acquired 2,500 shares (grant or award)
- 4 Grant or award Director acquired 2,500 shares (grant or award)
- 4 Grant or award Director acquired 2,500 shares (grant or award)
- 4 Grant or award Director acquired 2,500 shares (grant or award)
- 4 Grant or award Director acquired 2,500 shares (grant or award)
- 4 Grant or award Director acquired 2,500 shares (grant or award)
- 4 Shares withheld for taxes SVP, Gen Counsel & Corp Sec gave up 645 shares (to pay taxes)
- 4 Grant or award SVP, Finance acquired 7,250 shares (grant or award)
- 4 Grant or award SVP, Gen Counsel & Corp Sec acquired 13,750 shares (grant or award)
- 4 Shares withheld for taxes Chief Operating Officer gave up 1,189 shares (to pay taxes)
- 4 Shares withheld for taxes President and CFO gave up 1,727 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 3,099 shares (to pay taxes)
- 4 Open-market sale Director sold 315 shares at an average $46.12 ($14,526)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 12 of 22 · 421 filings